eCTD Submission to EMA: A Practical Guide for Regulatory Affairs Students

eCTD Submission to EMA: A Practical Guide for Regulatory Affairs Students

• 1.
  SANJIVANI COLLEGE OFPHARFMACEUTICAL EDUCATION AND RESEARCH KOPARGAON, AHEMADNAGAR, MAHARAHSTRA. MRA205P REGULATOY AFFAIRS PRACTICAL II TOPIC: Preparation of submission to EMA using eCTD software. Prepared by, Ms. Pholane Anushka Vijaykumar Drug Regulatory Affairs Semester-II
• 2.
  OVERVIEW • Aim 1 01 0203 04 05 Aim & Objectives Introduction to eCTD & Common Modules Step -by- Step Procedure of Submission Document Lifecycle Operations in eCTD Validation of eCTD Dossier & Common takeaways
• 3.
  Preparation of submissionto EMA using eCTD software. Aim 2
• 4.
  Objectives 3 • To understandthe basics of eCTD submissions. • To study the CTD Modules (1–5) used by EMA. • To learn the preparation and validation of an eCTD dossier. • To understand the electronic submission process to EMA. • To gain practical knowledge of eCTD software and dossier management.
• 5.
  Introduction to eCTD •eCTD (Electronic Common Technical Document) is the global standard for electronic regulatory submissions. • It was developed by the International Council for Harmonisation to harmonize the submission of pharmaceutical dossiers. • It organizes regulatory information into a standardized five-module structure for efficient review. • It enables electronic submission, validation, and lifecycle management of applications by regulatory authorities such as the European Medicines Agency. What is eCTD? 4
• 6.
  The Five-Module eCTDStructure 5 Module Title Contents Module 1 Regional Administrative Information Administrative documents, application forms, labeling, prescribing information, and region- specific requirements. Module 2 CTD Summaries Overall summaries and overviews of Quality, Non-clinical, and Clinical data. Module 3 Quality (CMC) Information on drug substance, drug product, manufacturing process, quality control, stability, and specifications. Module 4 Non-clinical Study Reports Pharmacology, pharmacokinetics, and toxicology study reports conducted in animals. Module 5 Clinical Study Reports Clinical trial reports, efficacy, safety, bioavailability/bioequivalence studies, and statistical analyses in humans.
• 7.
  6 01 Collect Regulatory Documents Gatherall required documents for the application. Ensure documents comply with International Council for Harmonisation and EMA requirements. 05 Build the eCTD Dossier Assign documents to the correct CTD sections and generate the XML backbone for the submission. 02 Organize Documents Classify documents into CTD Modules 1–5. Verify that each document is complete and correctly named. 06 Validate the Dossier Perform technical validation to identify and correct errors before submission. 03 Prepare Electronic Documents Convert all files into searchable PDF format and add bookmarks and hyperlinks where required. 07 Publish the eCTD Sequence Generate the final eCTD sequence, including all documents and metadata, ready for submission. 04 Create an eCTD Project Open the eCTD publishing software, create a new project, and import all prepared documents. 08 Submit to EMA Submit the validated eCTD dossier through the EMA Gateway or EMA Web Client and await acknowledgment and review. Step-by-Step Procedure
• 8.
  7 Document Lifecycle Operationsin eCTD Document lifecycle operations in eCTD are used to manage changes to documents throughout the regulatory submission process. Instead of resubmitting the entire dossier, only the affected documents are updated, ensuring efficient version control and review. Operation Purpose Example New Adds a document to the eCTD for the first time. Initial submission of a Stability Report. Replace Replaces an existing document with a revised version. Updated Clinical Study Report after corrections. Append Adds additional information to an existing document without replacing it. Submission of additional stability data. Delete Removes a document that is no longer applicable. Withdrawal of an incorrect document from the dossier.
• 9.
  8 Validation is theprocess of checking an eCTD submission to ensure that it complies with ICH eCTD specifications and European Medicines Agency technical requirements before it is submitted. Types of Validation 1. Technical Validation – Checks XML structure, file formats, hyperlinks, and folder structure. 2. Business Validation – Checks application-specific information and compliance with regulatory requirements. Validation Checks ✔ Correct CTD folder structure. ✔ Valid XML backbone. ✔ Correct sequence number. ✔ All required documents are present. ✔ Searchable PDF files. ✔ Working hyperlinks and bookmarks. ✔ Correct file names and metadata. ✔ No missing or corrupted files. Validation of eCTD Dossier
• 10.
  Common Takeaways ofthe Practical • Gained an understanding of the eCTD submission process for the European Medicines Agency. • Learned the structure and contents of CTD Modules 1–5. • Understood the preparation, validation, and publishing of an eCTD dossier. • Learned the importance of XML backbone and document lifecycle management. • Recognized the role of eCTD software in ensuring accurate and compliant submissions. • Appreciated the importance of ICH-compliant electronic submissions for efficient regulatory review. 9
• 11.
  References • European MedicinesAgency. (2025). eSubmission: Electronic Common Technical Document (eCTD). Retrieved from https://www.ema.europa.eu/en/human-regulatory-overview/research-de velopment/scientific-guidelines/ich-guidelines • European Medicines Agency. (2010). ICH M2: Electronic Common Technical Document (eCTD). Retrieved from https://www.ema.europa.eu/en/ich-m2-electronic-common-technical-do cument-ectd-scientific-guideline 10
• 12.
  THANK YOU